Skip to main content
. 2018 Sep 25;74(8):1217–1224. doi: 10.1093/gerona/gly218

Figure 1.

Figure 1.

Percentage of participants with solicited systemic symptoms before vaccination and solicited local and systemic symptoms over Days 0–6 post-first vaccinationa (Total Vaccinated Cohort). aRecombinant zoster vaccine Dose 1 administered on Day 0. *Nausea, vomiting, diarrhea, and/or abdominal pain; **≥37.5°C. GI = gastrointestinal.